Norursodeoxycholic Acid vs. Placebo in NASH

Clinical trial NCT05083390 · UNKNOWN

Trial details

NCT number: NCT05083390
Sponsor: Dr. Falk Pharma GmbH
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Nonalcoholic Steatohepatitis

Start date: 2019-07-08
Primary completion: 2025-01-01
Enrollment: 363

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.